25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Aspira Womens Health Inc
Buy, Hold or Sell?

Let's analyze Aspira Womens Health Inc together

I guess you are interested in Aspira Womens Health Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Aspira Womens Health Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Aspira Womens Health Inc

I send you an email if I find something interesting about Aspira Womens Health Inc.

1. Quick Overview

1.1. Quick analysis of Aspira Womens Health Inc (30 sec.)










1.2. What can you expect buying and holding a share of Aspira Womens Health Inc? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
12.8%

What is your share worth?

Current worth
$-0.15
Expected worth in 1 year
$-0.30
How sure are you?
30.8%

+ What do you gain per year?

Total Gains per Share
$-0.15
Return On Investment
-20.4%

For what price can you sell your share?

Current Price per Share
$0.73
Expected price per share
$0.6679 - $1.38
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Aspira Womens Health Inc (5 min.)




Live pricePrice per Share (EOD)
$0.73
Intrinsic Value Per Share
$-9.71 - $3.04
Total Value Per Share
$-9.86 - $2.89

2.2. Growth of Aspira Womens Health Inc (5 min.)




Is Aspira Womens Health Inc growing?

Current yearPrevious yearGrowGrow %
How rich?-$2.5m$1.5m-$4.1m-162.9%

How much money is Aspira Womens Health Inc making?

Current yearPrevious yearGrowGrow %
Making money-$3.9m-$4.5m$599.7k15.4%
Net Profit Margin-172.6%-198.7%--

How much money comes from the company's main activities?

2.3. Financial Health of Aspira Womens Health Inc (5 min.)




2.4. Comparing to competitors in the Diagnostics & Research industry (5 min.)




  Industry Rankings (Diagnostics & Research)  


Richest
#122 / 136

Most Revenue
#110 / 136

Most Profit
#85 / 136

Most Efficient
#112 / 136
3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Aspira Womens Health Inc?

Welcome investor! Aspira Womens Health Inc's management wants to use your money to grow the business. In return you get a share of Aspira Womens Health Inc.

First you should know what it really means to hold a share of Aspira Womens Health Inc. And how you can make/lose money.

Speculation

The Price per Share of Aspira Womens Health Inc is $0.73. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Aspira Womens Health Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Aspira Womens Health Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $-0.15. Based on the TTM, the Book Value Change Per Share is $-0.04 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.18 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Aspira Womens Health Inc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.21-29.2%-0.23-32.1%-0.27-37.4%-0.33-45.4%0.1520.5%
Usd Book Value Change Per Share0.079.8%-0.04-5.1%-0.18-24.3%-0.05-6.2%-0.02-3.2%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.1114.8%
Usd Total Gains Per Share0.079.8%-0.04-5.1%-0.18-24.3%-0.05-6.2%0.0811.6%
Usd Price Per Share0.81-1.80-2.34-2.60-1.98-
Price to Earnings Ratio-0.95--1.83--2.81--2.20--1.74-
Price-to-Total Gains Ratio11.35--24.21--181.24--49.53--25.52-
Price to Book Ratio-5.36--16.65--57.96--12.96--4.70-
Price-to-Total Gains Ratio11.35--24.21--181.24--49.53--25.52-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.73
Number of shares1369
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.04-0.05
Usd Total Gains Per Share-0.04-0.05
Gains per Quarter (1369 shares)-50.95-62.02
Gains per Year (1369 shares)-203.81-248.09
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-204-2140-248-258
20-408-4180-496-506
30-611-6220-744-754
40-815-8260-992-1002
50-1019-10300-1240-1250
60-1223-12340-1489-1498
70-1427-14380-1737-1746
80-1630-16420-1985-1994
90-1834-18460-2233-2242
100-2038-20500-2481-2490

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.03.00.00.0%0.011.00.00.0%0.019.00.00.0%3.036.00.07.7%4.091.00.04.2%
Book Value Change Per Share1.02.00.033.3%1.010.00.09.1%3.015.01.015.8%9.027.03.023.1%20.069.06.021.1%
Dividend per Share0.00.03.00.0%0.00.011.00.0%0.00.019.00.0%5.00.034.012.8%5.00.090.05.3%
Total Gains per Share1.02.00.033.3%1.010.00.09.1%3.015.01.015.8%12.024.03.030.8%23.066.06.024.2%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Aspira Womens Health Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.071-0.037+152%-0.178+349%-0.045+164%-0.023+133%
Book Value Per Share---0.151-0.152+0%0.096-258%0.829-118%0.713-121%
Current Ratio--0.7520.835-10%1.837-59%3.690-80%3.990-81%
Debt To Asset Ratio--1.5301.552-1%0.921+66%0.651+135%0.484+216%
Debt To Equity Ratio----0%3.620-100%1.115-100%0.820-100%
Dividend Per Share----0%-0%-0%0.108-100%
Enterprise Value--8354513.00024345140.000-66%36864066.695-77%54032191.716-85%42315348.808-80%
Eps---0.213-0.234+10%-0.273+28%-0.331+56%0.150-242%
Ev To Ebitda Ratio---0.558-1.361+144%-2.030+264%-2.386+328%-2.335+319%
Ev To Sales Ratio--0.9252.734-66%4.002-77%8.652-89%10.413-91%
Free Cash Flow Per Share---0.175-0.223+27%-0.294+68%-0.319+82%-0.258+47%
Free Cash Flow To Equity Per Share--0.070-0.014+121%-0.232+430%-0.033+147%-0.019+128%
Gross Profit Margin--1.6041.539+4%1.540+4%1.142+40%1.325+21%
Intrinsic Value_10Y_max--3.042--------
Intrinsic Value_10Y_min---9.711--------
Intrinsic Value_1Y_max---0.840--------
Intrinsic Value_1Y_min---1.327--------
Intrinsic Value_3Y_max---1.652--------
Intrinsic Value_3Y_min---3.705--------
Intrinsic Value_5Y_max---1.412--------
Intrinsic Value_5Y_min---5.754--------
Market Cap12167129.000-11%13500513.00030001140.000-55%39037316.695-65%43366296.979-69%33022066.757-59%
Net Profit Margin---1.572-1.726+10%-1.987+26%-3.068+95%-4.307+174%
Operating Margin---1.669-1.890+13%-2.271+36%-3.449+107%-4.524+171%
Operating Ratio--2.6592.887-8%3.171-16%4.418-40%5.478-51%
Pb Ratio-4.828+10%-5.357-16.654+211%-57.963+982%-12.961+142%-4.701-12%
Pe Ratio-0.858+10%-0.952-1.834+93%-2.805+195%-2.201+131%-1.742+83%
Price Per Share0.730-11%0.8101.800-55%2.342-65%2.602-69%1.981-59%
Price To Free Cash Flow Ratio-1.041+10%-1.155-1.903+65%-2.804+143%-2.420+110%-2.168+88%
Price To Total Gains Ratio10.233-11%11.355-24.208+313%-181.239+1696%-49.526+536%-25.524+325%
Quick Ratio--0.6200.665-7%1.612-62%3.494-82%3.800-84%
Return On Assets---0.745-0.761+2%-0.416-44%-0.342-54%-0.307-59%
Return On Equity----0%-2.0890%-0.6500%-0.5410%
Total Gains Per Share--0.071-0.037+152%-0.178+349%-0.045+164%0.085-16%
Usd Book Value---2520000.000-2530666.667+0%1592750.000-258%13824947.368-118%11884923.077-121%
Usd Book Value Change Per Share--0.071-0.037+152%-0.178+349%-0.045+164%-0.023+133%
Usd Book Value Per Share---0.151-0.152+0%0.096-258%0.829-118%0.713-121%
Usd Dividend Per Share----0%-0%-0%0.108-100%
Usd Enterprise Value--8354513.00024345140.000-66%36864066.695-77%54032191.716-85%42315348.808-80%
Usd Eps---0.213-0.234+10%-0.273+28%-0.331+56%0.150-242%
Usd Free Cash Flow---2922000.000-3709666.667+27%-4901500.000+68%-5318368.421+82%-4302897.436+47%
Usd Free Cash Flow Per Share---0.175-0.223+27%-0.294+68%-0.319+82%-0.258+47%
Usd Free Cash Flow To Equity Per Share--0.070-0.014+121%-0.232+430%-0.033+147%-0.019+128%
Usd Market Cap12167129.000-11%13500513.00030001140.000-55%39037316.695-65%43366296.979-69%33022066.757-59%
Usd Price Per Share0.730-11%0.8101.800-55%2.342-65%2.602-69%1.981-59%
Usd Profit---3547000.000-3902000.000+10%-4501750.000+27%-5227473.684+47%-4389717.949+24%
Usd Revenue--2257000.0002277666.667-1%2294250.000-2%1836842.105+23%1299794.872+74%
Usd Total Gains Per Share--0.071-0.037+152%-0.178+349%-0.045+164%0.085-16%
 EOD+1 -7MRQTTM+24 -12YOY+20 -175Y+21 -1610Y+18 -21

3.3 Fundamental Score

Let's check the fundamental score of Aspira Womens Health Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-0.858
Price to Book Ratio (EOD)Between0-1-4.828
Net Profit Margin (MRQ)Greater than0-1.572
Operating Margin (MRQ)Greater than0-1.669
Quick Ratio (MRQ)Greater than10.620
Current Ratio (MRQ)Greater than10.752
Debt to Asset Ratio (MRQ)Less than11.530
Debt to Equity Ratio (MRQ)Less than10.000
Return on Equity (MRQ)Greater than0.150.000
Return on Assets (MRQ)Greater than0.05-0.745
Total1/10 (10.0%)

3.4 Technical Score

Let's check the technical score of Aspira Womens Health Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5038.552
Ma 20Greater thanMa 500.783
Ma 50Greater thanMa 1000.834
Ma 100Greater thanMa 2000.953
OpenGreater thanClose0.760
Total1/5 (20.0%)

4. In-depth Analysis

4.1 About Aspira Womens Health Inc

Aspira Women's Health Inc., together with its subsidiaries, discovers, develops, and commercializes of noninvasive AI-powered diagnostic tests for gynecologic diseases in the United States. The company's products include Ova1Plus, a qualitative serum test to assess the likelihood of malignancy in women with an ovarian adnexal mass; Overa, a biomarker test intended to maintain Ova1's high sensitivity; and OvaWatch, a laboratory developed tests to assist in the initial clinical assessment of malignancy risk in all women thought to have an indeterminate or benign adnexal mass. It is also developing OvaMDx, a multi-marker test that combines serum proteins, clinical data, and miRNA for assessing the risk of ovarian cancer in women with an adnexal mass; EndoCheck, a protein biomarker designed to identify ovarian endometriomas; and EndoMDx for the identification of endometriosis. The company also operates Aspira Labs, a laboratory that specializes in applying biomarker-based technologies to address critical needs in the management of gynecologic cancers and disease. The company serves physicians, physician office laboratories, and national and regional laboratories. The company distributes its products through its national sales force, its platform Aspira Synergy, and a marketing and distribution agreement with BioReference Health, LLC. It has a research agreement with Harvard's Dana-Farber Cancer Institute, Brigham and Women's Hospital, and Medical University of Lodz for the generation of a multi-omic, non-invasive diagnostic aid to identify endometriosis based on circulating miRNAs and proteins; and a strategic alliance with Quest Diagnostics, Incorporated. The company was formerly known as Vermillion, Inc. and changed its name to Aspira Women's Health Inc. in June 2020. Aspira Women's Health Inc. was incorporated in 1993 and is based in Austin, Texas.

Fundamental data was last updated by Penke on 2024-12-05 13:21:07.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just not able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is unable to pay all its debts by selling its assets.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Aspira Womens Health Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Aspira Womens Health Inc to the Diagnostics & Research industry mean.
  • A Net Profit Margin of -157.2% means that $-1.57 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Aspira Womens Health Inc:

  • The MRQ is -157.2%. The company is making a huge loss. -2
  • The TTM is -172.6%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-157.2%TTM-172.6%+15.5%
TTM-172.6%YOY-198.7%+26.1%
TTM-172.6%5Y-306.8%+134.2%
5Y-306.8%10Y-430.7%+123.9%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ-157.2%-2.6%-154.6%
TTM-172.6%-9.1%-163.5%
YOY-198.7%-0.8%-197.9%
5Y-306.8%-3.0%-303.8%
10Y-430.7%-0.7%-430.0%
4.3.1.2. Return on Assets

Shows how efficient Aspira Womens Health Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Aspira Womens Health Inc to the Diagnostics & Research industry mean.
  • -74.5% Return on Assets means that Aspira Womens Health Inc generated $-0.75 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Aspira Womens Health Inc:

  • The MRQ is -74.5%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -76.1%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-74.5%TTM-76.1%+1.6%
TTM-76.1%YOY-41.6%-34.5%
TTM-76.1%5Y-34.2%-41.9%
5Y-34.2%10Y-30.7%-3.5%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ-74.5%-1.2%-73.3%
TTM-76.1%-2.1%-74.0%
YOY-41.6%-0.9%-40.7%
5Y-34.2%-0.3%-33.9%
10Y-30.7%-0.5%-30.2%
4.3.1.3. Return on Equity

Shows how efficient Aspira Womens Health Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Aspira Womens Health Inc to the Diagnostics & Research industry mean.
  • 0.0% Return on Equity means Aspira Womens Health Inc generated $0.00 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Aspira Womens Health Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-208.9%+208.9%
TTM-5Y-65.0%+65.0%
5Y-65.0%10Y-54.1%-10.9%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ--0.1%+0.1%
TTM--2.1%+2.1%
YOY-208.9%0.3%-209.2%
5Y-65.0%-0.9%-64.1%
10Y-54.1%-0.8%-53.3%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Aspira Womens Health Inc.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Aspira Womens Health Inc is operating .

  • Measures how much profit Aspira Womens Health Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Aspira Womens Health Inc to the Diagnostics & Research industry mean.
  • An Operating Margin of -166.9% means the company generated $-1.67  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Aspira Womens Health Inc:

  • The MRQ is -166.9%. The company is operating very inefficient. -2
  • The TTM is -189.0%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-166.9%TTM-189.0%+22.1%
TTM-189.0%YOY-227.1%+38.1%
TTM-189.0%5Y-344.9%+155.9%
5Y-344.9%10Y-452.4%+107.6%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ-166.9%-12.0%-154.9%
TTM-189.0%-16.5%-172.5%
YOY-227.1%2.5%-229.6%
5Y-344.9%-1.3%-343.6%
10Y-452.4%2.4%-454.8%
4.3.2.2. Operating Ratio

Measures how efficient Aspira Womens Health Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Diagnostics & Research industry mean).
  • An Operation Ratio of 2.66 means that the operating costs are $2.66 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Aspira Womens Health Inc:

  • The MRQ is 2.659. The company is inefficient in keeping operating costs low. -1
  • The TTM is 2.887. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ2.659TTM2.887-0.228
TTM2.887YOY3.171-0.284
TTM2.8875Y4.418-1.532
5Y4.41810Y5.478-1.060
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ2.6591.230+1.429
TTM2.8871.278+1.609
YOY3.1711.266+1.905
5Y4.4181.206+3.212
10Y5.4781.191+4.287
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Aspira Womens Health Inc.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Aspira Womens Health Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Diagnostics & Research industry mean).
  • A Current Ratio of 0.75 means the company has $0.75 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Aspira Womens Health Inc:

  • The MRQ is 0.752. The company is just not able to pay all its short-term debts. -1
  • The TTM is 0.835. The company is just not able to pay all its short-term debts. -1
Trends
Current periodCompared to+/- 
MRQ0.752TTM0.835-0.082
TTM0.835YOY1.837-1.002
TTM0.8355Y3.690-2.855
5Y3.69010Y3.990-0.300
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ0.7522.116-1.364
TTM0.8352.050-1.215
YOY1.8372.606-0.769
5Y3.6902.646+1.044
10Y3.9903.229+0.761
4.4.3.2. Quick Ratio

Measures if Aspira Womens Health Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Aspira Womens Health Inc to the Diagnostics & Research industry mean.
  • A Quick Ratio of 0.62 means the company can pay off $0.62 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Aspira Womens Health Inc:

  • The MRQ is 0.620. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.665. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.620TTM0.665-0.045
TTM0.665YOY1.612-0.947
TTM0.6655Y3.494-2.829
5Y3.49410Y3.800-0.306
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ0.6201.229-0.609
TTM0.6651.276-0.611
YOY1.6121.742-0.130
5Y3.4942.094+1.400
10Y3.8002.435+1.365
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Aspira Womens Health Inc.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Aspira Womens Health Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Aspira Womens Health Inc to Diagnostics & Research industry mean.
  • A Debt to Asset Ratio of 1.53 means that Aspira Womens Health Inc assets are financed with 153.0% credit (debt) and the remaining percentage (100% - 153.0%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Aspira Womens Health Inc:

  • The MRQ is 1.530. The company is unable to pay all its debts by selling its assets. -2
  • The TTM is 1.552. The company is unable to pay all its debts by selling its assets. -2
Trends
Current periodCompared to+/- 
MRQ1.530TTM1.552-0.023
TTM1.552YOY0.921+0.631
TTM1.5525Y0.651+0.901
5Y0.65110Y0.484+0.167
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ1.5300.441+1.089
TTM1.5520.441+1.111
YOY0.9210.359+0.562
5Y0.6510.427+0.224
10Y0.4840.443+0.041
4.5.4.2. Debt to Equity Ratio

Measures if Aspira Womens Health Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Aspira Womens Health Inc to the Diagnostics & Research industry mean.
  • A Debt to Equity ratio of 0.0% means that company has $0.00 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Aspira Womens Health Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY3.620-3.620
TTM-5Y1.115-1.115
5Y1.11510Y0.820+0.295
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.686-0.686
TTM-0.673-0.673
YOY3.6200.502+3.118
5Y1.1150.666+0.449
10Y0.8200.717+0.103
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Aspira Womens Health Inc generates.

  • Above 15 is considered overpriced but always compare Aspira Womens Health Inc to the Diagnostics & Research industry mean.
  • A PE ratio of -0.95 means the investor is paying $-0.95 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Aspira Womens Health Inc:

  • The EOD is -0.858. Based on the earnings, the company is expensive. -2
  • The MRQ is -0.952. Based on the earnings, the company is expensive. -2
  • The TTM is -1.834. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.858MRQ-0.952+0.094
MRQ-0.952TTM-1.834+0.882
TTM-1.834YOY-2.805+0.972
TTM-1.8345Y-2.201+0.367
5Y-2.20110Y-1.742-0.458
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD-0.858-0.263-0.595
MRQ-0.952-0.432-0.520
TTM-1.834-0.775-1.059
YOY-2.805-0.065-2.740
5Y-2.2012.176-4.377
10Y-1.7423.736-5.478
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Aspira Womens Health Inc:

  • The EOD is -1.041. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -1.155. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -1.903. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-1.041MRQ-1.155+0.114
MRQ-1.155TTM-1.903+0.748
TTM-1.903YOY-2.804+0.901
TTM-1.9035Y-2.420+0.517
5Y-2.42010Y-2.168-0.252
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD-1.041-0.583-0.458
MRQ-1.155-1.123-0.032
TTM-1.903-1.123-0.780
YOY-2.804-2.360-0.444
5Y-2.420-2.334-0.086
10Y-2.168-2.168+0.000
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Aspira Womens Health Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Diagnostics & Research industry mean).
  • A PB ratio of -5.36 means the investor is paying $-5.36 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Aspira Womens Health Inc:

  • The EOD is -4.828. Based on the equity, the company is expensive. -2
  • The MRQ is -5.357. Based on the equity, the company is expensive. -2
  • The TTM is -16.654. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-4.828MRQ-5.357+0.529
MRQ-5.357TTM-16.654+11.296
TTM-16.654YOY-57.963+41.309
TTM-16.6545Y-12.961-3.693
5Y-12.96110Y-4.701-8.260
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD-4.8282.169-6.997
MRQ-5.3572.222-7.579
TTM-16.6542.222-18.876
YOY-57.9632.296-60.259
5Y-12.9613.467-16.428
10Y-4.7014.140-8.841
4.6.2. Total Gains per Share

4.7 Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Aspira Womens Health Inc.

4.8.1. Institutions holding Aspira Womens Health Inc

Institutions are holding 13.889% of the shares of Aspira Womens Health Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-09-30Armistice Capital, LLC7.53570.01631256000788000168.3761
2024-09-30Vanguard Group Inc1.64450274089-3318-1.1961
2024-06-30National Asset Management Inc1.41830.00923639611102288.5527
2024-09-30Geode Capital Management, LLC0.53940898991700723.3318
2024-06-30BlackRock Inc0.44030733801061416.9104
2024-09-30Northern Trust Corp0.198103301500
2024-09-30TWO SIGMA SECURITIES, LLC0.18330.00043055117059126.4379
2024-06-30Bank of America Corp0.1761029346-8-0.0273
2024-09-30XTX Topco Ltd0.16530.00162754716515149.7009
2024-09-30Northeast Financial Consultants, Inc0.14060.00082343600
2024-09-30State Street Corp0.118501974900
2024-09-30Millennium Management LLC0.096016000160000
2024-09-30PNC Financial Services Group Inc0.0901500000
2024-06-30M&T Bank Corp0.090.00011499900
2024-09-30Tower Research Capital LLC0.03630.00016050-619-9.2818
2024-06-30Advisor Group Holdings, Inc.0.0138023051399154.415
2024-09-30JPMorgan Chase & Co0.012402065-14-0.6734
2024-09-30UBS Group AG0.01110184579675.8818
2024-09-30Morgan Stanley - Brokerage Accounts0.009701616-3228-66.6391
2024-09-30Operose Advisors LLC0.0060.0003100000
Total 12.92540.02862154288+971225+45.1%

4.9.2. Funds holding Aspira Womens Health Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-10-31Vanguard Total Stock Mkt Idx Inv1.1694019490600
2024-10-31Vanguard Institutional Extnd Mkt Idx Tr0.46620.00017770300
2024-09-30Fidelity Extended Market Index0.35510.0001591781113723.1823
2024-11-27iShares Micro-Cap ETF0.120.00162000400
2024-09-30Fidelity Nasdaq Composite Index0.07290.00011215200
2024-09-30NT Ext Equity Mkt Idx Fd - NL0.05690.0001948000
2024-09-30Fidelity Series Total Market Index0.05640939300
2024-09-30BlackRock Extended Equity Market K0.05070.00018442-4-0.0474
2024-09-30NT Ext Equity Mkt Idx Fd - DC - NL - T20.04580.00017638230.302
2024-09-30NT Ext Equity Mkt Idx Fd - L0.0410.0001682700
2024-09-30Northern Trust Extended Eq Market Idx0.0410.0001682700
2024-09-30Fidelity Total Market Index0.0390650400
2024-09-301290 VT Micro Cap K0.01590.0013264726470
2024-09-30Spartan Total Market Index Pool E0.01460243200
2024-10-31State St US Extended Mkt Indx NL Cl C0.0110.0001183500
2024-10-31Vanguard U.S. Eq Idx £ Acc0.00890148000
2024-09-30BNYM Mellon SL Market Completion UC10.00820.0002136010.0736
2024-09-30Extended Equity Market Fund M0.00640.00011071-3-0.2793
2024-09-30NT Ext Eq Mkt Indx Fd DC Lending Tier 50.00630.0001105420.1901
2024-06-30SSgA U.S. Total Market Index Strategy0.0045075322342.0755
Total 2.59020.0042431686+14026+3.2%

5.3. Insider Transactions

Insiders are holding 30.943% of the shares of Aspira Womens Health Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2024-05-31Nicole SandfordBUY94932.42
2023-12-06Minh Hoang MerchantSELL9803.37
2023-12-06Nicole SandfordBUY50003.36
3rd party ad coffee SUPPORTERis ad-free.

5. Financial Statements




5.1. Latest Balance Sheet

Balance Sheet of 2024-09-30. Currency in USD. All numbers in thousands.

Summary
Total Assets4,759
Total Liabilities7,279
Total Stockholder Equity-2,520
 As reported
Total Liabilities 7,279
Total Stockholder Equity+ -2,520
Total Assets = 4,759

Assets

Total Assets4,759
Total Current Assets4,113
Long-term Assets646
Total Current Assets
Cash And Cash Equivalents 2,133
Net Receivables 1,254
Inventory 290
Other Current Assets 436
Total Current Assets  (as reported)4,113
Total Current Assets  (calculated)4,113
+/-0
Long-term Assets
Property Plant Equipment 614
Long-term Assets Other 32
Long-term Assets  (as reported)646
Long-term Assets  (calculated)646
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities5,466
Long-term Liabilities1,813
Total Stockholder Equity-2,520
Total Current Liabilities
Short-term Debt 421
Short Long Term Debt 229
Accounts payable 2,551
Other Current Liabilities 2,494
Total Current Liabilities  (as reported)5,466
Total Current Liabilities  (calculated)5,695
+/- 229
Long-term Liabilities
Long term Debt 1,334
Capital Lease Obligations 579
Long-term Liabilities  (as reported)1,813
Long-term Liabilities  (calculated)1,913
+/- 100
Total Stockholder Equity
Common Stock16
Retained Earnings -530,009
Other Stockholders Equity 527,473
Total Stockholder Equity (as reported)-2,520
Total Stockholder Equity (calculated)-2,520
+/-0
Other
Capital Stock16
Cash and Short Term Investments 2,133
Common Stock Shares Outstanding 15,406
Liabilities and Stockholders Equity 4,759
Net Debt 9
Net Invested Capital -957
Net Working Capital -1,353
Property Plant and Equipment Gross 614
Short Long Term Debt Total 2,142



5.2. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2024-09-302024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-312007-12-312007-09-302007-06-302007-03-312006-12-312006-09-302006-06-302006-03-312005-12-312005-09-302005-06-302005-03-312004-12-312004-09-302004-06-302004-03-312003-12-312003-09-302003-06-302003-03-312002-12-312002-09-302002-06-302002-03-312001-12-312001-09-302001-06-302001-03-312000-12-312000-09-302000-06-302000-03-31
> Total Assets 
0
0
109,459
118,948
118,948
111,179
110,740
106,816
106,816
96,238
90,748
87,615
80,511
76,949
103,669
102,026
94,311
81,174
69,920
74,377
62,311
53,785
59,609
52,811
46,745
40,952
34,643
23,016
23,016
13,155
26,867
24,053
17,555
12,683
7,150
3,858
2,023
1,485
2,600
4,609
38,732
29,898
26,367
24,035
40,907
37,085
28,046
23,111
20,541
18,918
16,882
8,634
6,506
16,891
15,084
30,640
27,272
23,511
18,407
24,174
18,675
12,335
25,389
20,960
15,872
13,899
10,682
8,019
10,442
8,173
9,678
7,497
7,497
16,121
13,474
11,408
11,408
18,152
16,533
13,828
13,828
13,091
21,265
19,605
62,297
55,829
48,047
41,079
30,861
24,016
23,942
17,373
11,496
7,720
8,662
0
7,164
3,961
4,759
4,7593,9617,16408,6627,72011,49617,37323,94224,01630,86141,07948,04755,82962,29719,60521,26513,09113,82813,82816,53318,15211,40811,40813,47416,1217,4977,4979,6788,17310,4428,01910,68213,89915,87220,96025,38912,33518,67524,17418,40723,51127,27230,64015,08416,8916,5068,63416,88218,91820,54123,11128,04637,08540,90724,03526,36729,89838,7324,6092,6001,4852,0233,8587,15012,68317,55524,05326,86713,15523,01623,01634,64340,95246,74552,81159,60953,78562,31174,37769,92081,17494,311102,026103,66976,94980,51187,61590,74896,238106,816106,816110,740111,179118,948118,948109,45900
   > Total Current Assets 
0
0
103,891
112,948
112,948
97,506
86,484
81,291
81,291
78,064
63,424
63,150
58,592
51,787
75,021
73,281
65,081
52,200
42,007
57,270
45,660
38,224
44,901
41,146
35,902
31,220
25,790
20,040
20,040
10,575
24,599
17,575
9,815
6,603
2,722
2,821
1,106
656
1,795
3,894
38,063
29,757
26,158
23,829
40,690
36,820
27,797
22,893
20,331
18,732
16,719
8,492
6,377
16,788
14,997
30,249
26,888
23,095
17,877
23,666
18,085
11,710
24,534
19,366
13,931
11,792
8,589
6,108
8,711
6,613
8,303
6,305
6,305
15,286
12,773
10,788
10,788
17,565
16,050
13,410
13,410
12,690
20,251
18,603
61,373
54,907
47,188
40,005
29,800
22,956
22,976
16,309
10,528
6,862
7,572
0
6,122
3,251
4,113
4,1133,2516,12207,5726,86210,52816,30922,97622,95629,80040,00547,18854,90761,37318,60320,25112,69013,41013,41016,05017,56510,78810,78812,77315,2866,3056,3058,3036,6138,7116,1088,58911,79213,93119,36624,53411,71018,08523,66617,87723,09526,88830,24914,99716,7886,3778,49216,71918,73220,33122,89327,79736,82040,69023,82926,15829,75738,0633,8941,7956561,1062,8212,7226,6039,81517,57524,59910,57520,04020,04025,79031,22035,90241,14644,90138,22445,66057,27042,00752,20065,08173,28175,02151,78758,59263,15063,42478,06481,29181,29186,48497,506112,948112,948103,89100
       Cash And Cash Equivalents 
0
0
18,010
107,633
107,633
76,949
53,842
48,319
48,319
46,185
32,098
25,145
25,513
19,524
34,057
32,853
29,309
22,766
14,912
35,392
30,058
21,256
28,913
25,738
24,384
20,576
15,024
17,711
17,711
9,553
19,498
7,617
8,283
5,307
1,877
2,464
748
304
1,460
3,440
37,734
28,583
25,292
22,914
40,228
36,285
27,228
22,477
19,850
18,290
16,328
8,007
5,834
16,392
14,604
29,504
25,991
22,186
16,762
22,965
17,241
10,878
23,974
18,642
13,067
11,062
8,080
5,242
7,897
6,028
7,752
5,539
5,539
14,135
11,760
9,360
9,360
16,179
14,636
11,703
11,703
10,935
18,836
16,631
59,369
52,993
44,870
37,180
26,855
20,480
20,551
13,306
7,535
4,246
5,100
0
3,413
962
2,133
2,1339623,41305,1004,2467,53513,30620,55120,48026,85537,18044,87052,99359,36916,63118,83610,93511,70311,70314,63616,1799,3609,36011,76014,1355,5395,5397,7526,0287,8975,2428,08011,06213,06718,64223,97410,87817,24122,96516,76222,18625,99129,50414,60416,3925,8348,00716,32818,29019,85022,47727,22836,28540,22822,91425,29228,58337,7343,4401,4603047482,4641,8775,3078,2837,61719,4989,55317,71117,71115,02420,57624,38425,73828,91321,25630,05835,39214,91222,76629,30932,85334,05719,52425,51325,14532,09846,18548,31948,31953,84276,949107,633107,63318,01000
       Short-term Investments 
0
0
0
0
0
13,621
21,250
21,273
21,273
17,515
13,463
14,713
10,765
8,707
13,847
14,463
10,340
7,021
4,053
2,175
2,190
2,206
2,224
2,240
0
0
0
0
0
0
4,000
8,875
0
0
0
0
0
0
0
0
0
465
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000000000000000000000000000000000000000004650000000008,8754,0000000002,2402,2242,2062,1902,1754,0537,02110,34014,46313,8478,70710,76514,71313,46317,51521,27321,27321,25013,62100000
       Net Receivables 
0
0
84,264
3,024
3,024
3,987
5,726
5,652
5,652
7,765
9,898
13,627
12,607
13,812
16,751
14,787
13,394
8,876
8,836
10,937
4,758
6,758
6,237
5,828
5,070
4,185
3,985
29
29
19
0
19
51
51
31
31
0
0
0
0
24
164
261
136
91
115
114
99
114
107
128
137
184
156
166
373
169
190
179
167
160
165
68
87
117
243
131
275
326
214
221
205
205
707
656
786
786
800
996
924
924
819
848
865
952
1,073
1,103
1,027
1,136
1,112
1,201
1,245
1,554
1,638
1,590
0
1,531
1,445
1,254
1,2541,4451,53101,5901,6381,5541,2451,2011,1121,1361,0271,1031,07395286584881992492499680078678665670720520522121432627513124311787681651601671791901693731661561841371281071149911411591136261164240000313151511901929293,9854,1855,0705,8286,2376,7584,75810,9378,8368,87613,39414,78716,75113,81212,60713,6279,8987,7655,6525,6525,7263,9873,0243,02484,26400
       Other Current Assets 
0
0
205
0
969
1,423
1,824
0
2,158
1,832
1,993
2,815
2,766
2,063
2,768
2,878
2,972
3,481
2,886
1,847
1,626
1,462
1,479
1,746
1,442
1,798
2,526
0
2,300
1,003
1,101
1,064
1,481
1,245
814
326
358
352
335
454
305
545
605
779
371
420
455
317
367
335
263
348
359
240
227
372
728
719
936
534
684
667
411
550
676
407
286
498
398
269
175
459
459
334
242
550
550
496
389
0
758
870
522
1,077
981
740
1,078
1,624
1,620
1,173
944
1,442
1,137
398
581
0
942
618
436
43661894205813981,1371,4429441,1731,6201,6241,0787409811,07752287075803894965505502423344594591752693984982864076765504116676845349367197283722272403593482633353673174554203717796055453054543353523583268141,2451,4811,0641,1011,0032,30002,5261,7981,4421,7461,4791,4621,6261,8472,8863,4812,9722,8782,7682,0632,7662,8151,9931,8322,15801,8241,423969020500
   > Long-term Assets 
0
0
5,568
6,000
6,000
13,673
24,256
25,525
25,525
18,174
27,324
24,465
21,919
25,162
28,648
28,745
29,230
28,974
27,913
17,107
16,651
15,561
14,708
11,665
10,843
9,732
8,853
0
2,976
2,580
2,268
6,478
7,740
6,080
4,428
1,037
917
829
805
715
669
141
209
206
217
265
249
218
210
186
163
142
129
103
87
391
384
416
530
508
590
625
855
1,594
1,941
2,107
2,093
1,911
1,731
1,560
1,375
1,192
1,192
835
701
620
620
587
483
418
418
401
1,014
1,002
924
922
859
1,074
1,061
1,060
966
1,064
968
858
1,090
0
1,042
710
646
6467101,04201,0908589681,0649661,0601,0611,0748599229241,0021,0144014184184835876206207018351,1921,1921,3751,5601,7311,9112,0932,1071,9411,594855625590508530416384391871031291421631862102182492652172062091416697158058299171,0374,4286,0807,7406,4782,2682,5802,97608,8539,73210,84311,66514,70815,56116,65117,10727,91328,97429,23028,74528,64825,16221,91924,46527,32418,17425,52525,52524,25613,6736,0006,0005,56800
       Property Plant Equipment 
0
0
4,570
4,687
4,687
5,786
9,579
10,228
10,228
10,838
12,435
13,370
13,696
13,758
14,279
15,891
15,797
15,863
15,207
9,315
9,044
8,216
7,630
7,320
6,755
5,910
5,435
2,260
2,260
1,889
1,613
1,938
1,630
1,305
742
611
516
426
341
189
143
130
197
194
205
253
237
216
202
186
163
142
121
103
87
391
384
416
530
508
492
535
765
1,504
1,933
2,107
2,093
1,911
1,731
1,549
1,364
1,181
1,181
835
701
608
608
472
399
353
353
360
1,014
989
924
922
859
810
811
753
716
650
570
603
821
0
751
679
614
61467975108216035706507167538118108599229249891,0143603533533994726086087018351,1811,1811,3641,5491,7311,9112,0932,1071,9331,504765535492508530416384391871031211421631862022162372532051941971301431893414265166117421,3051,6301,9381,6131,8892,2602,2605,4355,9106,7557,3207,6308,2169,0449,31515,20715,86315,79715,89114,27913,75813,69613,37012,43510,83810,22810,2289,5795,7864,6874,6874,57000
       Goodwill 
0
0
0
0
0
0
0
0
0
1,252
2,742
0
2,870
2,870
2,870
0
0
0
3,908
2,529
2,529
2,529
2,529
76
76
76
76
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
392,600
392,800
389,700
388,600
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000000000000388,600389,700392,800392,60000000000000000000000000000000000000000767676762,5292,5292,5292,5293,9080002,8702,8702,87002,7421,252000000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
9,053,200
8,621,200
8,054,800
7,787,700
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000000000000007,787,7008,054,8008,621,2009,053,20000000000000000000000000000000000000000000000000000000000000000000
       Intangible Assets 
0
0
455
379
379
227
7,090
6,709
6,709
5,040
7,575
7,496
7,289
10,431
10,144
9,879
10,639
10,397
10,222
5,569
5,440
5,289
5,124
2,493
2,252
2,055
1,856
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
113,500
111,100
104,700
104,200
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000000000000104,200104,700111,100113,500000000000000000000000000000000000000001,8562,0552,2522,4935,1245,2895,4405,56910,22210,39710,6399,87910,14410,4317,2897,4967,5755,0406,7096,7097,09022737937945500
       Other Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
437,200
417,400
634,600
468,100
0
0
0
0
0
0
0
147
115
84
65
49
41
0
0
0
0
0
264
250
307
250
414
0
0
0
0
0
0
0
000000041425030725026400000414965841151470000000468,100634,600417,400437,20000000000000000000000000000000000000000000000000000000000000000000
> Total Liabilities 
0
0
5,465
5,796
5,796
6,910
12,034
13,587
13,587
15,808
17,105
19,229
20,476
23,168
51,285
53,969
54,036
53,156
50,914
47,662
44,859
45,220
43,875
46,288
45,193
46,479
46,767
32,917
32,917
35,407
34,959
35,515
34,110
33,163
32,015
32,926
33,802
34,925
43,520
31,926
33,221
24,602
21,887
19,419
19,143
19,694
14,871
12,752
11,815
11,753
11,490
3,967
4,229
4,392
4,839
3,874
4,348
5,769
5,832
4,919
3,485
3,114
3,273
3,414
2,995
4,394
4,392
4,257
3,903
3,646
3,757
4,090
4,090
4,053
3,764
4,256
4,256
4,786
4,706
5,090
5,090
5,824
6,715
9,886
9,972
8,991
9,543
10,907
9,117
9,894
12,764
10,642
10,669
8,248
9,321
0
8,527
7,670
7,279
7,2797,6708,52709,3218,24810,66910,64212,7649,8949,11710,9079,5438,9919,9729,8866,7155,8245,0905,0904,7064,7864,2564,2563,7644,0534,0904,0903,7573,6463,9034,2574,3924,3942,9953,4143,2733,1143,4854,9195,8325,7694,3483,8744,8394,3924,2293,96711,49011,75311,81512,75214,87119,69419,14319,41921,88724,60233,22131,92643,52034,92533,80232,92632,01533,16334,11035,51534,95935,40732,91732,91746,76746,47945,19346,28843,87545,22044,85947,66250,91453,15654,03653,96951,28523,16820,47619,22917,10515,80813,58713,58712,0346,9105,7965,7965,46500
   > Total Current Liabilities 
0
0
4,602
4,928
4,928
6,088
9,125
10,401
10,401
12,347
13,514
15,483
16,606
17,831
18,685
21,311
21,241
19,826
17,623
17,338
14,885
15,421
12,903
14,016
11,582
11,634
10,738
7,046
7,046
6,393
8,531
9,041
7,718
6,726
5,682
6,548
80
1,241
2,442
4,530
14,606
9,523
13,139
10,103
10,299
11,051
6,386
11,476
10,704
10,756
10,607
3,197
3,573
3,849
4,410
3,558
4,146
5,681
5,832
4,919
3,485
3,114
3,202
3,351
2,940
2,589
2,641
2,561
2,263
2,061
2,229
2,609
2,609
2,666
2,424
2,964
2,964
3,561
3,537
3,978
3,978
4,199
4,615
6,400
6,148
5,791
6,409
7,840
6,139
7,044
7,297
5,775
5,911
5,374
5,162
0
5,293
5,458
5,466
5,4665,4585,29305,1625,3745,9115,7757,2977,0446,1397,8406,4095,7916,1486,4004,6154,1993,9783,9783,5373,5612,9642,9642,4242,6662,6092,6092,2292,0612,2632,5612,6412,5892,9403,3513,2023,1143,4854,9195,8325,6814,1463,5584,4103,8493,5733,19710,60710,75610,70411,4766,38611,05110,29910,10313,1399,52314,6064,5302,4421,241806,5485,6826,7267,7189,0418,5316,3937,0467,04610,73811,63411,58214,01612,90315,42114,88517,33817,62319,82621,24121,31118,68517,83116,60615,48313,51412,34710,40110,4019,1256,0884,9284,9284,60200
       Short-term Debt 
0
0
464
416
416
386
571
527
527
440
475
503
501
887
956
986
994
1,081
1,102
941
826
766
584
398
212
22
12
0
0
0
2,460
2,471
2,482
2,494
2,500
2,500
0
0
0
0
2,500
0
5,000
5,000
5,000
5,000
0
7,000
7,000
7,000
7,000
1,106
1,106
1,106
1,106
1,106
1,106
1,106
1,106
1,106
0
0
0
0
0
180
182
182
186
188
191
185
185
187
188
189
189
191
192
193
193
587
485
1,633
1,090
455
256
261
806
611
416
1,244
1,060
753
691
0
853
659
421
42165985306917531,0601,2444166118062612564551,0901,633485587193193192191189189188187185185191188186182182180000001,1061,1061,1061,1061,1061,1061,1061,1061,1067,0007,0007,0007,00005,0005,0005,0005,00002,50000002,5002,5002,4942,4822,4712,46000012222123985847668269411,1021,08199498695688750150347544052752757138641641646400
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,317,000
817,000
816,000
817,000
0
0
0
0
0
0
0
190
191
192
193
194
587
476
1,610
1,053
403
200
980
742
543
343
1,167
977
565
455
0
665
482
229
22948266504555659771,1673435437429802004031,0531,6104765871941931921911900000000817,000816,000817,0001,317,00000000000000000000000000000000000000000000000000000000000000000000
       Accounts payable 
0
0
1,170
0
919
2,581
3,296
0
3,216
3,504
4,655
5,605
5,715
5,797
4,114
5,062
4,617
6,334
4,603
3,369
2,536
3,593
2,439
3,188
2,390
1,647
2,223
0
2,401
2,620
2,177
2,975
2,648
1,690
1,126
1,676
3
537
985
2,227
2,731
2,150
1,105
998
1,132
1,670
2,162
1,331
714
582
661
525
794
656
422
541
620
1,264
1,144
1,123
1,295
533
803
988
672
503
501
881
568
300
514
745
745
783
495
950
950
811
879
1,158
1,158
1,122
1,315
1,149
1,587
1,436
1,155
1,501
1,298
1,374
1,893
881
867
1,072
1,382
0
1,643
1,943
2,551
2,5511,9431,64301,3821,0728678811,8931,3741,2981,5011,1551,4361,5871,1491,3151,1221,1581,1588798119509504957837457455143005688815015036729888035331,2951,1231,1441,2646205414226567945256615827141,3312,1621,6701,1329981,1052,1502,7312,22798553731,6761,1261,6902,6482,9752,1772,6202,40102,2231,6472,3903,1882,4393,5932,5363,3694,6036,3344,6175,0624,1145,7975,7155,6054,6553,5043,21603,2962,58191901,17000
       Other Current Liabilities 
0
0
2,968
0
3,593
2,143
3,670
0
4,636
4,955
5,095
5,514
6,396
6,535
8,331
9,495
9,799
7,132
7,321
7,499
6,791
6,197
5,518
6,298
5,123
6,212
4,934
0
4,600
3,742
3,863
3,568
2,588
2,542
2,056
2,372
77
704
1,457
2,303
10,655
6,058
5,690
3,056
3,234
3,380
3,223
2,592
2,255
2,321
1,870
1,057
964
1,129
1,485
1,241
1,523
2,096
2,078
2,178
2,190
2,581
2,399
2,323
2,268
1,890
1,958
1,494
1,509
1,573
1,462
29
1,679
1,696
1,741
1,825
1,825
2,559
2,466
39
2,627
2,490
2,815
3,618
3,471
3,900
4,998
6,078
4,035
5,059
4,988
3,650
3,984
3,549
3,089
0
2,797
2,856
2,494
2,4942,8562,79703,0893,5493,9843,6504,9885,0594,0356,0784,9983,9003,4713,6182,8152,4902,627392,4662,5591,8251,8251,7411,6961,679291,4621,5731,5091,4941,9581,8902,2682,3232,3992,5812,1902,1782,0782,0961,5231,2411,4851,1299641,0571,8702,3212,2552,5923,2233,3803,2343,0565,6906,05810,6552,3031,457704772,3722,0562,5422,5883,5683,8633,7424,60004,9346,2125,1236,2985,5186,1976,7917,4997,3217,1329,7999,4958,3316,5356,3965,5145,0954,9554,63603,6702,1433,59302,96800
   > Long-term Liabilities 
0
0
863
868
868
822
2,909
3,186
3,186
3,461
3,591
3,746
3,870
5,337
32,600
32,658
32,795
33,330
33,291
30,324
29,974
29,799
30,972
32,272
33,611
34,845
36,029
0
25,871
29,014
26,428
26,474
26,392
26,437
26,333
26,378
33,722
33,684
41,078
27,396
18,615
15,079
8,748
9,316
8,844
8,643
8,485
1,276
1,111
997
883
770
656
543
429
316
202
88
0
0
2,190
2,581
71
63
55
1,805
1,751
1,696
1,640
1,585
1,528
1,481
1,481
1,387
1,340
1,292
1,292
1,225
1,169
1,112
1,112
1,625
2,100
3,486
3,824
3,200
3,134
3,067
2,978
2,850
5,467
4,867
4,758
2,874
4,159
0
3,234
2,212
1,813
1,8132,2123,23404,1592,8744,7584,8675,4672,8502,9783,0673,1343,2003,8243,4862,1001,6251,1121,1121,1691,2251,2921,2921,3401,3871,4811,4811,5281,5851,6401,6961,7511,8055563712,5812,19000882023164295436567708839971,1111,2768,4858,6438,8449,3168,74815,07918,61527,39641,07833,68433,72226,37826,33326,43726,39226,47426,42829,01425,871036,02934,84533,61132,27230,97229,79929,97430,32433,29133,33032,79532,65832,6005,3373,8703,7463,5913,4613,1863,1862,90982286886886300
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,281
1,225
1,169
1,099
1,050
0
0
3,077
3,428
2,818
2,768
0
0
2,536
0
0
2,204
1,334
0
0
0
0
0
000001,3342,204002,536002,7682,8183,4283,077001,0501,0991,1691,2251,2810000000000000000000000000000000000000000000000000000000000000000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
8,600,300
8,693,400
8,407,000
8,634,100
0
0
0
0
0
0
0
0
29
21
0
1
10
0
0
0
0
0
0
0
0
2,748
2,280
0
0
0
0
0
0
0
00000002,2802,7480000000010102129000000008,634,1008,407,0008,693,4008,600,30000000000000000000000000000000000000000000000000000000000000000000
> Total Stockholder Equity
0
0
103,994
113,152
113,152
104,269
98,706
93,229
93,229
80,430
73,643
68,354
60,035
53,781
52,384
47,892
40,275
28,018
19,006
26,715
17,452
8,565
15,734
6,523
1,552
-5,527
-12,124
0
-9,901
-22,252
-8,092
-11,462
-16,555
-20,480
-24,865
-29,068
-31,779
-33,440
-40,920
-27,317
5,511
5,296
4,480
4,616
21,764
17,391
13,175
10,359
8,726
7,165
5,392
4,667
2,277
12,499
10,245
26,766
22,924
17,742
12,575
19,255
15,190
9,221
22,116
17,546
12,877
9,505
6,290
3,762
6,539
4,527
5,921
3,407
3,407
12,068
9,710
7,152
7,152
13,366
11,827
8,738
8,738
7,267
14,550
9,719
52,325
46,838
38,504
30,172
21,744
14,122
11,178
6,731
827
-528
-659
0
-1,363
-3,709
-2,520
-2,520-3,709-1,3630-659-5288276,73111,17814,12221,74430,17238,50446,83852,3259,71914,5507,2678,7388,73811,82713,3667,1527,1529,71012,0683,4073,4075,9214,5276,5393,7626,2909,50512,87717,54622,1169,22115,19019,25512,57517,74222,92426,76610,24512,4992,2774,6675,3927,1658,72610,35913,17517,39121,7644,6164,4805,2965,511-27,317-40,920-33,440-31,779-29,068-24,865-20,480-16,555-11,462-8,092-22,252-9,9010-12,124-5,5271,5526,52315,7348,56517,45226,71519,00628,01840,27547,89252,38453,78160,03568,35473,64380,43093,22993,22998,706104,269113,152113,152103,99400
   Common Stock
0
0
26
0
27
27
27
0
27
27
27
27
27
29
29
29
29
29
29
29
29
30
36
36
36
36
36
0
39
39
64
6
6
6
6
6
6
6
7
8
10
10
10
11
15
15
15
15
15
15
15
15
15
23
23
36
36
36
36
43
43
42
52
52
52
52
52
52
56
56
60
60
60
75
75
75
75
94
97
97
97
101
104
105
112
112
112
112
112
112
124
125
8
9
11
0
12
13
16
161312011981251241121121121121121121051041019797979475757575606060565652525252525242434336363636232315151515151515151511101010876666666643939036363636363029292929292929292727272727027272702600
   Retained Earnings Total Equity00000-507,282-504,96500-489,23900-462,767-453,060-445,986-440,06600000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Accumulated Other Comprehensive Income 
0
0
-1,597
-1,933
-1,933
-1,933
-1,933
-5,928
-5,928
-5,928
-5,928
-2,638
-1,071
-56
758
2,340
2,091
2,300
2,832
-86
-20
-65
-86
-204
-172
-79
-76
-5,912
-71
-40
-102
-221
-640
-277
-80
-162
-236
-173
-106
-46
-47
-104
-159
-156
-157
-155
-152
-153
-156
-154
-154
-263
0
0
0
-334
0
0
0
-452
0
0
0
-654
0
0
0
-1,369
-1,369
0
0
-2,139
-2,139
0
0
-2,750
-2,750
0
0
-2,381
-2,381
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000-2,381-2,38100-2,750-2,75000-2,139-2,13900-1,369-1,369000-654000-452000-334000-263-154-154-156-153-152-155-157-156-159-104-47-46-106-173-236-162-80-277-640-221-102-40-71-5,912-76-79-172-204-86-65-20-862,8322,3002,0912,340758-56-1,071-2,638-5,928-5,928-5,928-5,928-1,933-1,933-1,933-1,933-1,59700
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
414,202
428,226
430,504
430,802
431,072
0
0
449,680
498,199
499,786
501,159
0
0
503,249
0
0
505,784
506,745
0
0
0
0
0
00000506,745505,78400503,24900501,159499,786498,199449,68000431,072430,802430,504428,226414,2020000000000000000000000000000000000000000000000000000000000000000000000000000
   Treasury Stock000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
0
176,759
163,947
163,947
166,862
168,215
173,831
173,831
175,492
176,612
174,738
174,048
182,382
185,408
186,043
186,156
186,832
186,817
187,133
187,136
187,334
202,348
202,485
202,946
203,509
203,925
0
207,991
208,482
227,796
227,895
228,067
228,240
228,402
228,560
228,693
228,762
232,229
252,196
296,609
297,149
299,124
303,270
324,706
326,044
326,476
326,796
326,942
327,353
327,601
328,097
328,278
340,609
340,669
359,328
359,139
359,512
359,936
371,137
370,757
369,638
387,669
388,736
388,310
388,687
388,948
390,635
394,712
395,060
398,959
401,539
401,539
413,445
413,739
416,751
416,751
428,226
430,504
0
433,183
436,864
448,431
449,680
498,199
499,786
501,159
501,788
502,628
503,249
504,851
505,504
505,784
506,745
514,544
0
521,557
522,740
527,473
527,473522,740521,5570514,544506,745505,784505,504504,851503,249502,628501,788501,159499,786498,199449,680448,431436,864433,1830430,504428,226416,751416,751413,739413,445401,539401,539398,959395,060394,712390,635388,948388,687388,310388,736387,669369,638370,757371,137359,936359,512359,139359,328340,669340,609328,278328,097327,601327,353326,942326,796326,476326,044324,706303,270299,124297,149296,609252,196232,229228,762228,693228,560228,402228,240228,067227,895227,796208,482207,9910203,925203,509202,946202,485202,348187,334187,136187,133186,817186,832186,156186,043185,408182,382174,048174,738176,612175,492173,831173,831168,215166,862163,947163,947176,75900



5.3. Balance Sheets

Currency in USD. All numbers in thousands.